Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates

William Hogan, Marie Térèse Little, Eustacia Zellmer, Anke Friedetzky, Razvan Diaconescu, Serina Gisburne, Richard Lee, Christian Kuhr, Rainer Storb

Research output: Contribution to journalArticle

37 Citations (Scopus)

Abstract

We studied the value of postgrafting immunosuppression with sirolimus (SRL) and cyclosporine (CSP) in enhancing engraftment of dog leukocyte antigen-identical littermate marrow after nonmyeloablative conditioning in a canine model. Dogs received either 2 Gy (n=7) or 1 Gy (n=5) total body irradiation (TBI), followed by postgrafting immunosuppression with SRL and CSP. In the first cohort, all 7 dogs showed rapid initial engraftment. One engrafted dog died on day 21 due to hemorrhagic pneumonitis. Durable engraftment was seen in 5 of 6 remaining dogs, with a median follow-up of >48 (range, >32 to >56) weeks. The sixth dog rejected the marrow graft (as assessed by variable number of tandem repeats) at 11 weeks; however, a subsequent skin graft from the same marrow donor did not undergo acute cellular rejection, suggesting donor-specific tolerance. In the second cohort, all 5 dogs rejected the marrow graft at a median of 9 weeks (range, 3-11 weeks). We conclude that SRL/CSP is as effective as a previously studied combination of mycophenolate mofetil and CSP at establishing durable marrow engraftment after sublethal conditioning.

Original languageEnglish (US)
Pages (from-to)489-495
Number of pages7
JournalBiology of Blood and Marrow Transplantation
Volume9
Issue number8
DOIs
StatePublished - Aug 2003
Externally publishedYes

Fingerprint

Chimerism
Whole-Body Irradiation
Sirolimus
Immunosuppression
Cyclosporine
Transplantation
Bone Marrow
Dogs
Transplants
Mycophenolic Acid
Minisatellite Repeats
HLA Antigens
Canidae
Pneumonia
Skin

Keywords

  • Engraftment
  • Graft rejection
  • Hematopoietic cell transplantation

ASJC Scopus subject areas

  • Transplantation

Cite this

Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. / Hogan, William; Little, Marie Térèse; Zellmer, Eustacia; Friedetzky, Anke; Diaconescu, Razvan; Gisburne, Serina; Lee, Richard; Kuhr, Christian; Storb, Rainer.

In: Biology of Blood and Marrow Transplantation, Vol. 9, No. 8, 08.2003, p. 489-495.

Research output: Contribution to journalArticle

Hogan, William ; Little, Marie Térèse ; Zellmer, Eustacia ; Friedetzky, Anke ; Diaconescu, Razvan ; Gisburne, Serina ; Lee, Richard ; Kuhr, Christian ; Storb, Rainer. / Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates. In: Biology of Blood and Marrow Transplantation. 2003 ; Vol. 9, No. 8. pp. 489-495.
@article{31ffd0196aec4a3b90165a7b4e47c843,
title = "Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates",
abstract = "We studied the value of postgrafting immunosuppression with sirolimus (SRL) and cyclosporine (CSP) in enhancing engraftment of dog leukocyte antigen-identical littermate marrow after nonmyeloablative conditioning in a canine model. Dogs received either 2 Gy (n=7) or 1 Gy (n=5) total body irradiation (TBI), followed by postgrafting immunosuppression with SRL and CSP. In the first cohort, all 7 dogs showed rapid initial engraftment. One engrafted dog died on day 21 due to hemorrhagic pneumonitis. Durable engraftment was seen in 5 of 6 remaining dogs, with a median follow-up of >48 (range, >32 to >56) weeks. The sixth dog rejected the marrow graft (as assessed by variable number of tandem repeats) at 11 weeks; however, a subsequent skin graft from the same marrow donor did not undergo acute cellular rejection, suggesting donor-specific tolerance. In the second cohort, all 5 dogs rejected the marrow graft at a median of 9 weeks (range, 3-11 weeks). We conclude that SRL/CSP is as effective as a previously studied combination of mycophenolate mofetil and CSP at establishing durable marrow engraftment after sublethal conditioning.",
keywords = "Engraftment, Graft rejection, Hematopoietic cell transplantation",
author = "William Hogan and Little, {Marie T{\'e}r{\`e}se} and Eustacia Zellmer and Anke Friedetzky and Razvan Diaconescu and Serina Gisburne and Richard Lee and Christian Kuhr and Rainer Storb",
year = "2003",
month = "8",
doi = "10.1016/S1083-8791(03)00148-4",
language = "English (US)",
volume = "9",
pages = "489--495",
journal = "Biology of Blood and Marrow Transplantation",
issn = "1083-8791",
publisher = "Elsevier Inc.",
number = "8",

}

TY - JOUR

T1 - Postgrafting immunosuppression with sirolimus and cyclosporine facilitates stable mixed hematopoietic chimerism in dogs given sublethal total body irradiation before marrow transplantation from DLA-identical littermates

AU - Hogan, William

AU - Little, Marie Térèse

AU - Zellmer, Eustacia

AU - Friedetzky, Anke

AU - Diaconescu, Razvan

AU - Gisburne, Serina

AU - Lee, Richard

AU - Kuhr, Christian

AU - Storb, Rainer

PY - 2003/8

Y1 - 2003/8

N2 - We studied the value of postgrafting immunosuppression with sirolimus (SRL) and cyclosporine (CSP) in enhancing engraftment of dog leukocyte antigen-identical littermate marrow after nonmyeloablative conditioning in a canine model. Dogs received either 2 Gy (n=7) or 1 Gy (n=5) total body irradiation (TBI), followed by postgrafting immunosuppression with SRL and CSP. In the first cohort, all 7 dogs showed rapid initial engraftment. One engrafted dog died on day 21 due to hemorrhagic pneumonitis. Durable engraftment was seen in 5 of 6 remaining dogs, with a median follow-up of >48 (range, >32 to >56) weeks. The sixth dog rejected the marrow graft (as assessed by variable number of tandem repeats) at 11 weeks; however, a subsequent skin graft from the same marrow donor did not undergo acute cellular rejection, suggesting donor-specific tolerance. In the second cohort, all 5 dogs rejected the marrow graft at a median of 9 weeks (range, 3-11 weeks). We conclude that SRL/CSP is as effective as a previously studied combination of mycophenolate mofetil and CSP at establishing durable marrow engraftment after sublethal conditioning.

AB - We studied the value of postgrafting immunosuppression with sirolimus (SRL) and cyclosporine (CSP) in enhancing engraftment of dog leukocyte antigen-identical littermate marrow after nonmyeloablative conditioning in a canine model. Dogs received either 2 Gy (n=7) or 1 Gy (n=5) total body irradiation (TBI), followed by postgrafting immunosuppression with SRL and CSP. In the first cohort, all 7 dogs showed rapid initial engraftment. One engrafted dog died on day 21 due to hemorrhagic pneumonitis. Durable engraftment was seen in 5 of 6 remaining dogs, with a median follow-up of >48 (range, >32 to >56) weeks. The sixth dog rejected the marrow graft (as assessed by variable number of tandem repeats) at 11 weeks; however, a subsequent skin graft from the same marrow donor did not undergo acute cellular rejection, suggesting donor-specific tolerance. In the second cohort, all 5 dogs rejected the marrow graft at a median of 9 weeks (range, 3-11 weeks). We conclude that SRL/CSP is as effective as a previously studied combination of mycophenolate mofetil and CSP at establishing durable marrow engraftment after sublethal conditioning.

KW - Engraftment

KW - Graft rejection

KW - Hematopoietic cell transplantation

UR - http://www.scopus.com/inward/record.url?scp=0346363060&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0346363060&partnerID=8YFLogxK

U2 - 10.1016/S1083-8791(03)00148-4

DO - 10.1016/S1083-8791(03)00148-4

M3 - Article

C2 - 12931117

AN - SCOPUS:0346363060

VL - 9

SP - 489

EP - 495

JO - Biology of Blood and Marrow Transplantation

JF - Biology of Blood and Marrow Transplantation

SN - 1083-8791

IS - 8

ER -